Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

DGCI allows Serum Institute to export malaria vaccine to U.K.

The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine

The Hindu

2 Earnings Winners to Scoop Up During the Bear Market

The bear market has been brutal. Given the trend in inflation and weakening economy, it's unlikely to end soon. For investors, the best strategy is to use the adverse market conditions to scoop up stocks that have a long-term history of compounding earnings. Therefore, investors should consider buying Builders FirstSource…

StockNews.com

Pfizer COVID vaccine approved for all children aged over six months old

The Therapeutic Goods Administration approves Pfizer's paediatric dose of its COVID vaccine for children aged between six months and five years old.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

Interim tick for Pfizer infant booster

The Therapeutic Goods Administration has given provisional approval for Pfizer's COVID-19 booster to be used in children aged six months to five years.

AAP

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion.

Benzinga

Lab Monkeys Are the Latest Covid Shortage

Beijing’s ban on macaque exports—needed to test vaccines and other lifesaving drugs—could give its pharma industry an edge.

Businessweek

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session

Gainers

Benzinga

Read news from The Economist, FT, and more,
with one subscription

7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%

Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen

Benzinga

Lawmakers eye lame duck for unfinished business on insulin

WASHINGTON — A bipartisan Senate duo is still working to pass a bill to overhaul insulin prices, but the outlook is complicated by the messy drug pricing system, politics and a busy congressional calendar.

Tribune News Service

Opioid crisis cost U.S. nearly $1.5 trillion in 2020 -congressional report

Fueled by the COVID-19 pandemic, the economic toll of the opioid addiction and overdose crisis on the United States reached nearly $1.5 trillion in 2020 alone and is likely to grow, a congressional report seen by Reuters shows.

Reuters

Pharmaceuticals firm Vectura gets green light for £58m Bristol facility

The Wiltshire-based business specialises in respiratory medicines and inhaler devices

Birmingham Post

Medicinal cannabis companies fined almost $1m by TGA over false treatment claims

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy

The Guardian - AU

DEA: Fake pills containing fentanyl helping drive OD deaths

Federal officials say an increasing number of fake prescription pills containing potentially deadly fentanyl are helping drive overdose death rates to record levels in the U.S. And officials warn that some of the pills are being manufactured in rainbow colors designed to look like candy

The Independent UK

Pfizer pays $179m for Brisbane company behind smartphone app that claims to diagnose COVID

Recent studies had shown the app had a 92 per cent success rate in diagnosing the virus among symptomatic patients, but more clinical trials were needed for it to gain regulatory approval.

ABC News

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Millions of Americans will save on Medicare fees next year

For the first time in a decade, Americans will pay less next year on monthly premiums for Medicare’s Part B plan, which covers routine doctors’ visits and other outpatient care

Benzinga

Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.

Benzinga

Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage

Atai Life Sciences' (NASDAQ: ATAI) wholly-owned subsidiary EmpathBio has received Medsafe central regulatory and the Health and Disability Ethics Committees (HDEC) approvals to begin participant enrollment in its Phase 1 trial of proprietary MDMA-based drug EMP-01

Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Gainers

Get all your
news in one place.

100's of premium titles.
One news app.

Chronicle Live

Autumn Covid-19 vaccine roll-out to 'double your defences' ahead of uncertain winter

Vulnerable groups may have already been called to have their fourth Covid-19 jab

StockNews.com

1 Stock Living up to Its Name This Year

Biopharmaceutical company Bristol Myers Squibb (BMY) reported stable revenue growth for the second quarter thanks to outstanding clinical and operational performance. Furthermore, despite generating significant momentum over the past few months, the stock is trading at a discounted valuation. So, we think it may be prudent to scoop its shares…

The Independent UK

Biogen pays $900M to settle doctor kickback allegations

Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade them to prescribe its multiple sclerosis drugs

StockNews.com

3 Biotech Stocks to Sell Before the End of This Year

The biotech industry witnessed solid growth during the pandemic. However, that seems to be fading away amid the receding pandemic and growing recession concerns. So, it could be wise to avoid biotech stocks Ginkgo Bioworks Holdings (DNA), GeoVax Labs (GOVX), and Aditxt (ADTX), given their bleak fundamentals. Read on….

StockNews.com

3 Stocks to Get Bullish on Right Now

Record-high inflation, the Federal Reserve's hawkish stance, and growing recession fears have increased market volatility. Nevertheless, despite the unsettling macroenvironment, few stocks have delivered stable returns and could continue to beat the market based on their solid growth attributes. AbbVie Inc. (ABBV), J. Jill Inc. (JILL), and Bassett Furniture Industries…

The Independent UK

Insider Q&A: FDA official on vaping's "promise or peril"

The new chief at the Food and Drug Administration's tobacco center has inherited a raft of problems

The Independent UK

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11

1 … 126 127 128 129

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

336 stories

TGA

320 stories

South Gloucestershire Council

BristolMyers Squibb Company

95 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.